OraSure Technologies EBITDA Margin 2012-2025 | OSUR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for OraSure Technologies (OSUR) over the last 10 years. The current EBITDA margin for OraSure Technologies as of September 30, 2025 is .
| OraSure Technologies EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $0.13B | $-0.06B | -44.00% |
| 2025-06-30 | $0.14B | $-0.04B | -31.88% |
| 2025-03-31 | $0.16B | $-0.03B | -17.39% |
| 2024-12-31 | $0.19B | $-0.02B | -9.19% |
| 2024-09-30 | $0.22B | 0 | 0.00% |
| 2024-06-30 | $0.27B | $0.02B | 6.23% |
| 2024-03-31 | $0.30B | $0.02B | 6.91% |
| 2023-12-31 | $0.41B | $0.05B | 13.09% |
| 2023-09-30 | $0.45B | $0.07B | 14.38% |
| 2023-06-30 | $0.48B | $0.06B | 11.69% |
| 2023-03-31 | $0.47B | $0.03B | 7.17% |
| 2022-12-31 | $0.39B | $-0.01B | -1.55% |
| 2022-09-30 | $0.33B | $-0.03B | -9.45% |
| 2022-06-30 | $0.27B | $-0.05B | -17.29% |
| 2022-03-31 | $0.24B | $-0.02B | -9.84% |
| 2021-12-31 | $0.24B | $0.00B | 0.43% |
| 2021-09-30 | $0.23B | $0.02B | 7.26% |
| 2021-06-30 | $0.23B | $0.03B | 14.91% |
| 2021-03-31 | $0.20B | $0.02B | 11.56% |
| 2020-12-31 | $0.17B | $0.00B | 2.33% |
| 2020-09-30 | $0.16B | 0 | 0.00% |
| 2020-06-30 | $0.15B | $0.01B | 5.44% |
| 2020-03-31 | $0.16B | $0.02B | 14.01% |
| 2019-12-31 | $0.16B | $0.03B | 16.77% |
| 2019-09-30 | $0.16B | $0.03B | 21.29% |
| 2019-06-30 | $0.17B | $0.03B | 18.79% |
| 2019-03-31 | $0.17B | $0.03B | 18.24% |
| 2018-12-31 | $0.18B | $0.03B | 18.68% |
| 2018-09-30 | $0.18B | $0.03B | 17.93% |
| 2018-06-30 | $0.18B | $0.03B | 16.11% |
| 2018-03-31 | $0.18B | $0.03B | 17.05% |
| 2017-12-31 | $0.17B | $0.05B | 27.54% |
| 2017-09-30 | $0.15B | $0.04B | 28.67% |
| 2017-06-30 | $0.14B | $0.04B | 30.00% |
| 2017-03-31 | $0.13B | $0.04B | 30.53% |
| 2016-12-31 | $0.13B | $0.03B | 21.26% |
| 2016-09-30 | $0.12B | $0.02B | 19.35% |
| 2016-06-30 | $0.12B | $0.02B | 15.57% |
| 2016-03-31 | $0.12B | $0.02B | 14.05% |
| 2015-12-31 | $0.12B | $0.01B | 11.76% |
| 2015-09-30 | $0.12B | $0.01B | 6.03% |
| 2015-06-30 | $0.11B | $0.01B | 6.14% |
| 2015-03-31 | $0.11B | $0.01B | 6.36% |
| 2014-12-31 | $0.11B | $0.00B | 1.87% |
| 2014-09-30 | $0.11B | $0.01B | 10.28% |
| 2014-06-30 | $0.10B | $0.01B | 7.69% |
| 2014-03-31 | $0.10B | 0 | 0.00% |
| 2013-12-31 | $0.10B | $-0.01B | -5.05% |
| 2013-09-30 | $0.09B | $-0.02B | -18.48% |
| 2013-06-30 | $0.09B | $-0.02B | -20.22% |
| 2013-03-31 | $0.09B | $-0.02B | -18.18% |
| 2012-12-31 | $0.09B | $-0.01B | -10.23% |
| 2012-09-30 | $0.09B | $0.00B | -3.33% |
| 2012-06-30 | $0.09B | $-0.01B | -5.56% |
| 2012-03-31 | $0.09B | $-0.01B | -5.81% |
| 2011-12-31 | $0.08B | $-0.01B | -6.10% |
| 2011-09-30 | $0.08B | $-0.01B | -9.09% |
| 2011-06-30 | $0.07B | $0.00B | -4.05% |
| 2011-03-31 | $0.07B | $0.00B | -1.35% |
| 2010-12-31 | $0.08B | $0.00B | -1.33% |
| 2010-09-30 | $0.08B | $0.00B | -5.19% |
| 2010-06-30 | $0.08B | $0.00B | -3.75% |
| 2010-03-31 | $0.08B | $-0.01B | -8.97% |
| 2009-12-31 | $0.08B | $-0.01B | -7.79% |
| 2009-09-30 | $0.07B | $0.00B | -4.11% |
| 2009-06-30 | $0.07B | $-0.01B | -11.76% |
| 2009-03-31 | $0.07B | $-0.01B | -10.00% |
| 2008-12-31 | $0.07B | $-0.01B | -11.27% |
| 2008-09-30 | $0.07B | $-0.01B | -12.16% |
| 2008-06-30 | $0.08B | $-0.01B | -7.69% |
| 2008-03-31 | $0.08B | $0.00B | -2.50% |
| 2007-12-31 | $0.08B | $0.00B | 1.22% |
| 2007-09-30 | $0.08B | $0.00B | 3.75% |
| 2007-06-30 | $0.08B | $0.01B | 7.79% |
| 2007-03-31 | $0.07B | $0.01B | 9.46% |
| 2006-12-31 | $0.07B | $0.01B | 10.14% |
| 2006-09-30 | $0.07B | $0.01B | 13.04% |
| 2006-06-30 | $0.07B | $0.01B | 14.49% |
| 2006-03-31 | $0.07B | $0.01B | 14.71% |
| 2005-12-31 | $0.07B | $0.01B | 15.94% |
| 2005-09-30 | $0.07B | $0.01B | 12.31% |
| 2005-06-30 | $0.06B | $0.00B | 6.56% |
| 2005-03-31 | $0.06B | $0.00B | 5.26% |
| 2004-12-31 | $0.05B | $0.00B | 1.89% |
| 2004-09-30 | $0.05B | $0.00B | 3.92% |
| 2004-06-30 | $0.05B | $0.00B | 6.38% |
| 2004-03-31 | $0.04B | $0.00B | 4.55% |
| 2003-12-31 | $0.04B | $0.00B | 4.88% |
| 2003-09-30 | $0.04B | $0.00B | 5.41% |
| 2003-06-30 | $0.04B | $0.00B | 2.86% |
| 2003-03-31 | $0.03B | 0 | 0.00% |
| 2002-12-31 | $0.03B | $0.00B | -3.13% |
| 2002-09-30 | $0.03B | $0.00B | -12.50% |
| 2002-06-30 | $0.03B | $0.00B | -12.12% |
| 2002-03-31 | $0.03B | $0.00B | -8.82% |
| 2001-12-31 | $0.03B | $0.00B | -9.09% |
| 2001-09-30 | $0.03B | $-0.01B | -27.27% |
| 2001-06-30 | $0.03B | $-0.02B | -54.84% |
| 2001-03-31 | $0.03B | $-0.02B | -62.07% |
| 2000-12-31 | $0.03B | $-0.02B | -62.07% |
| 2000-09-30 | $0.02B | $-0.01B | -45.83% |
| 2000-06-30 | $0.02B | 0 | 0.00% |
| 2000-03-31 | $0.02B | 0 | 0.00% |
| 1999-12-31 | $0.01B | 0 | 0.00% |
| 1999-09-30 | $0.01B | $0.00B | 30.00% |
| 1999-06-30 | $0.01B | $0.00B | 30.00% |
| 1999-03-31 | $0.01B | $0.01B | 70.00% |
| 1998-12-31 | $0.01B | $0.01B | 100.00% |
| 1998-09-30 | $0.01B | $0.01B | 100.00% |
| 1998-06-30 | $0.01B | $0.01B | 88.89% |
| 1998-03-31 | $0.01B | $0.01B | 88.89% |
| 1997-12-31 | $0.01B | $0.01B | 50.00% |
| 1997-09-30 | $0.01B | $0.00B | 9.09% |
| 1997-06-30 | $0.01B | $0.00B | -9.09% |
| 1997-03-31 | $0.01B | $-0.01B | -66.67% |
| 1996-12-31 | $0.01B | $-0.01B | -100.00% |
| 1996-09-30 | $0.01B | $-0.01B | -140.00% |
| 1996-06-30 | $0.00B | $-0.01B | -275.00% |
| 1996-03-31 | $0.01B | $-0.01B | -260.00% |
| 1995-12-31 | $0.01B | $-0.02B | -266.67% |
| 1995-09-30 | $0.01B | $-0.02B | -300.00% |
| 1995-06-30 | $0.01B | $-0.02B | -300.00% |
| 1995-03-31 | $0.01B | $-0.02B | -360.00% |
| 1994-12-31 | $0.01B | $-0.02B | -340.00% |
| 1994-09-30 | $0.01B | $-0.02B | -320.00% |
| 1994-06-30 | $0.01B | $-0.02B | -300.00% |
| 1994-03-31 | $0.01B | $-0.01B | -280.00% |
| 1993-12-31 | $0.00B | $-0.01B | -325.00% |
| 1993-09-30 | $0.00B | $-0.01B | -325.00% |
| 1993-06-30 | $0.00B | $-0.01B | -275.00% |
| 1993-03-31 | $0.00B | $-0.01B | -250.00% |
| 1992-12-31 | $0.00B | $-0.01B | -225.00% |
| 1992-09-30 | $0.00B | $-0.01B | -200.00% |
| 1992-06-30 | $0.00B | $-0.01B | -200.00% |
| 1992-03-31 | $0.00B | $-0.01B | -175.00% |
| 1991-12-31 | $0.00B | $-0.01B | -150.00% |
| 1991-09-30 | $0.00B | $-0.01B | -125.00% |
| 1991-06-30 | $0.00B | $0.00B | -100.00% |
| 1991-03-31 | $0.00B | $0.00B | -100.00% |
| 1990-12-31 | $0.00B | $0.00B | -100.00% |
| 1990-09-30 | $0.00B | $0.00B | -100.00% |
| 1990-06-30 | $0.00B | $0.00B | -100.00% |
| 1990-03-31 | $0.00B | $0.00B | -100.00% |
| 1989-12-31 | $0.00B | $0.00B | -100.00% |
| 1989-09-30 | $0.00B | $0.00B | -100.00% |
| 1989-06-30 | $0.00B | $0.00B | -75.00% |
| 1989-03-31 | $0.00B | $0.00B | -100.00% |
| 1988-12-31 | $0.00B | $0.00B | -150.00% |
| 1988-09-30 | $0.00B | $0.00B | -300.00% |
| 1988-06-30 | $0.00B | $0.00B | 0.00% |
| 1988-03-31 | $0.00B | $0.00B | 0.00% |
| 1987-12-31 | $0.00B | $0.00B | 0.00% |
| 1987-09-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.197B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |